Related Articles

• Long‑term complete response in a patient with postoperative recurrent ALK‑rearranged lung adenocarcinoma treated with crizotinib: A case report
• Safety and efficacy of anaplastic lymphoma kinase tyrosine kinase inhibitors in non‑small cell lung cancer (Review)
• A pregnant patient with ALK‑positive non‑small cell lung cancer treated with alectinib: A case report and review of the literature
• Resistance to epithelial growth factor receptor tyrosine kinase inhibitors in a patient with transformation from lung adenocarcinoma to small cell lung cancer: A case report
• Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer